Stay updated on CMG901 Safety, Tolerability, PK, and Preliminary Efficacy Clinical Trial
Sign up to get notified when there's something new on the CMG901 Safety, Tolerability, PK, and Preliminary Efficacy Clinical Trial page.

Latest updates to the CMG901 Safety, Tolerability, PK, and Preliminary Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check29 days agoChange DetectedThe page has been updated to reflect a new completion status and a specific date of February 12, 2025, while previous statuses and dates have been removed.SummaryDifference2%
- Check36 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check43 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check58 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check65 days agoChange DetectedThe intervention type has been updated to 'Verified 2022-12 by Keymed Biosciences Co.Ltd' with the last known status as 'Recruiting', reflecting a revision from v2.13.3 to v2.14.0.SummaryDifference3%
Stay in the know with updates to CMG901 Safety, Tolerability, PK, and Preliminary Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMG901 Safety, Tolerability, PK, and Preliminary Efficacy Clinical Trial page.